Associate Professor of Medicine, Massachusetts General Hospital
Cardiology
Dr. Patrick T. Ellinor II, MD
|
|
Give Review
Patrick T. Ellinor II, MD is an expert in the field of Cardiology. He researched medicine at Stanford University School of Medicine. Stanford University School of Medicine is a top medical university. Stanford University School of Medicine has a rank of 2 in research and a 25 in primary care Doctor Patrick T. Ellinor II, MD has written publications. He has 98 publications published with PubMed. The lastest paper is: 'Programmed Ventricular Stimulation for Risk Stratification in the Brugada Syndrome: A Pooled Analysis.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Programmed Ventricular Stimulation for Risk Stratification in the Brugada Syndrome: A Pooled Analysis.
- Does Atrial Fibrillation Follow Function? Ion Channel Mutations and Lone Atrial Fibrillation.
- Atrial Flutter - Clinical Risk Factors and Adverse Outcomes in the Framingham Heart Study.
- Somatic mutations and Atrial fibrillation: the end or just the beginning?
- Next-generation sequencing for the diagnosis of cardiac arrhythmia Syndromes.
- Twelve-single nucleotide polymorphism genetic risk score identifies individuals at increased risk for future Atrial fibrillation and stroke.
- Plasma MicroRNAs are Associated with Atrial Fibrillation and Change after Catheter-ablation (the miRhythm Study).
- B-type natriuretic peptide and C-reactive protein in the prediction of Atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies.
- New classification scheme for Atrial fibrillation symptom severity and burden.
- Emerging directions in the genetics of Atrial fibrillation.
- Novel trafficking-defective HCN4 mutation is associated with early-onset Atrial fibrillation.
- Rapid Cellular Phenotyping of Human Pluripotent Stem Cell-Derived Cardiomyocytes using a Genetically Encoded Fluorescent Voltage Sensor.
- Relations between circulating microRNAs and Atrial fibrillation: Data from the Framingham Offspring Study.
- Novel Genetic Markers Associate with Atrial Fibrillation Risk in Europeans and Japanese.
- Overexpression of KCNN3 Results in Sudden Cardiac Death.
- Targeted sequencing in candidate genes for atrial fibrillation: the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Targeted Sequencing Study.
- Gene Expression and Genetic Variation in Human Atria.
- Genetic etiology and evaluation of sudden cardiac death.
- Reciprocal relations between physical disability, subjective health, and atrial fibrillation: The Framingham Heart Study.
- The QT Interval and Risk of Incident Atrial Fibrillation.
- miR-21 represses Pdcd4 during cardiac valvulogenesis.
- Risk assessment for incident Heart failure in individuals with atrial fibrillation.
- Common genetic variation near the connexin-43 gene is associated with resting Heart rate in African Americans: A genome-wide association study of 13,372 participants.
- Low serum magnesium and the development of atrial fibrillation in the community: the Framingham Heart Study.
- New advances in the genetic basis of Atrial fibrillation.
- Relation of Circulating Liver Transaminase Concentrations to Risk of New-Onset Atrial Fibrillation.
- Pathological role of serum- and glucocorticoid-regulated kinase 1 in adverse ventricular remodeling.
- Outcomes of Medicare beneficiaries undergoing catheter ablation for Atrial fibrillation.
- A meta-analysis of genome-wide association studies of the electrocardiographic early repolarization pattern.
- Meta-analysis identifies six new susceptibility loci for Atrial fibrillation.
- Renin-angiotensin-system modulators and the incidence of atrial fibrillation following hospitalization for Coronary artery disease.
- Plasma resistin, adiponectin, and risk of incident Atrial fibrillation: The Framingham Offspring Study.
- Unpredictable battery depletion of St Jude Atlas II and Atlas+ II HF implantable cardioverter-defibrillators.
- Next Steps in Cardiovascular Disease Genomic Research--Sequencing, Epigenetics, and Transcriptomics.
- White Blood Cell Count and Risk of Incident Atrial Fibrillation (From the Framingham Heart Study).
- Atrial fibrillation: current knowledge and future directions in epidemiology and genomics.
- Genetic variation in the alternative splicing regulator RBM20 is associated with dilated Cardiomyopathy.
- Insulin Resistance and Atrial Fibrillation (from the Framingham Heart Study).
- Vitamin D status is not related to development of Atrial fibrillation in the community.
- Large-Scale Candidate Gene Analysis in Whites and African-Americans Identifies IL6R Polymorphism in Relation to Atrial Fibrillation: The NHLBI CARe Project.
- Influence of Race on Atrial Fibrillation after Cardiac Surgery.
- HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies This document was developed as a partnership between t...
- American Heart Association Atrial Fibrillation Research Summit: A Conference Report From the American Heart Association.
- Elevation of parathyroid hormone levels in Atrial fibrillation.
- Atrial fibrillation and death after myocardial infarction: risk marker or causal mediator?
- Intermittent, erratic behaviour of an implantable cardioverter defibrillator secondary to a hidden magnetic source of interference.
- P wave duration and risk of longitudinal atrial fibrillation in Persons ≥ 60 years old (from the Framingham Heart Study).
- Pulmonary vein isolation with complex fractionated Atrial electrogram ablation for paroxysmal and nonparoxysmal Atrial fibrillation: A meta-analysis.
- Lack of replication in polymorphisms reported to be associated with Atrial fibrillation.
- A common connexin-40 gene promoter variant affects connexin-40 expression in human atria and is associated with Atrial fibrillation.
- Novel chemical suppressors of long QT Syndrome identified by an in vivo functional screen.
- P wave duration is associated with cardiovascular and all-cause mortality outcomes: the National Health and Nutrition Examination Survey.
- Association between familial Atrial fibrillation and risk of new-onset Atrial fibrillation.
- P-wave indices: derivation of reference values from the Framingham Heart Study.
- Independent susceptibility markers for Atrial fibrillation on chromosome 4q25.
- The impact of new and emerging clinical data on treatment strategies for Atrial fibrillation.
- Genome-wide association studies in cardiac electrophysiology: recent discoveries and implications for clinical practice.
- Pericardial fat is associated with prevalent atrial fibrillation: the Framingham Heart Study.
- Duffy antigen receptor for chemokines (Darc) polymorphism regulates circulating concentrations of monocyte chemoattractant protein-1 and other inflammatory mediators.
- Rare ion channel polymorphisms: separating signal from noise.
- Identification of a Kir3.4 mutation in congenital long QT Syndrome.
- Genetics of Atrial fibrillation: implications for future research directions and personalized medicine.
- Impact of segmental left ventricle lead position on cardiac resynchronization therapy outcomes.
- Arrhythmogenic right ventricular Cardiomyopathy.
- Atrial fibrillation in congestive Heart failure.
- Common variants in KCNN3 are associated with lone Atrial fibrillation.
- Amiodarone or procainamide for the termination of sustained stable ventricular tachycardia: an historical multicenter comparison.
- Genome-wide association study of PR interval.
- Top advances in functional genomics and translational biology for 2009.
- Relations of biomarkers of distinct pathophysiological pathways and Atrial fibrillation incidence in the community.
- P-wave indices, distribution and quality control assessment (from the Framingham Heart Study).
- N-terminal pro-B-type natriuretic peptide is a major predictor of the development of Atrial fibrillation: the Cardiovascular Health Study.
- Variation in the 4q25 chromosomal locus predicts atrial fibrillation after Coronary artery bypass graft surgery.
- Adenosine for wide-complex tachycardia: efficacy and safety.
- ACE I/D polymorphism associated with abnormal atrial and atrioventricular conduction in lone atrial fibrillation and structural Heart disease: implications for electri...
- Variants in ZFHX3 are associated with Atrial fibrillation in individuals of European ancestry.
- Mutation in the S3 segment of KCNQ1 results in familial lone Atrial fibrillation.
- The efficacy of implantable cardioverter-defibrillators in Heart transplant recipients: results from a multicenter registry.
- Prevention of atrial fibrillation: report from a national Heart, lung, and blood institute workshop.
- Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study.
- P wave indices: current status and future directions in epidemiology, clinical, and research applications.
- Timing of delayed perforation with the St. Jude Riata lead: a single-center experience and a review of the literature.
- Catheter ablation of peri-AV nodal atrial tachycardia from the nonCoronary cusp of the aortic valve.
- Ion channel mutations in AF: signal or noise?
- Ablation of Atrial flutter in a patient with situs inversus totalis using integration of real-time three-dimensional electroanatomical mapping.
- Increasing US emergency department visit rates and subsequent hospital admissions for Atrial fibrillation from 1993 to 2004.
- Cardiac sodium channel gene variants and sudden cardiac death in women.
- Cardiac sodium channel mutation in Atrial fibrillation.
- Genetics of Atrial fibrillation.
- The diagnosis and treatment of cardiac ion channelopathies: congenital long QT Syndrome and Brugada Syndrome.
- Increased incidence of subAcute lead perforation noted with one implantable cardioverter-defibrillator.
- Mutant desmocollin-2 causes arrhythmogenic right ventricular Cardiomyopathy.
- Factors affecting error in integration of electroanatomic mapping with CT and MR imaging during catheter ablation of Atrial fibrillation.
- Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute Heart failure.
- Fungal infection of implantable cardioverter-defibrillators: case series of five patients managed over 22 years.
- A novel locus for dilated Cardiomyopathy, diffuse myocardial fibrosis, and sudden death on chromosome 10q25-26.
- In vivo recording of adult zebrafish electrocardiogram and assessment of drug-induced QT prolongation.
Schools
Stanford Univ Sch Of Med
Brigham and Women39s Hospital
Brigham and Womens Hospital
Massachusetts General Hospital
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Automatic Implantable Cardioverter Defibrillator (ICD) Implantation
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- View All
Doctors Specialties
- Cardiology
- Clinical Cardiac Electrophysiology
Accepted Insurances
Education
-
Massachusetts General Hospital -
Stanford University School of Medicine
Hospital
-
Massachusetts General Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Christopher H. Newton-Cheh, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Owen C. Raffel, MB CHB
This Doctor is OpenDoctor Recommended.
|
|
|
Cynthia L. Browne, NP
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pipin Kojodjojo, PHD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ara L. Tachjian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel J. Pelchovitz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dan Blendea, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maria A. Rupnick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Apoor Patel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marc J. Semigran, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey Popma, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James M. Kirshenbaum, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles A. Boucher, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jenica N. Upshaw, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Iris Z. Jaffe, MD
This Doctor is OpenDoctor Recommended.
|